About Moby DickMDSativa Hybrid
Moby Dick is designed specifically as a strong medical strain. It is excellent for daytime use though patients may feel lazy a few hours after use.
Moby Dick is a Sativa-dominant strain. Its name reflects its massive yields, which reportedly can reach 1,500 grams per square meter. The THC concentration of this strain may be as high as 20%.
The effects of this strain are highly psychoactive, due to a high count of tetrahydrocannabivarin (THCV). It produces strong euphoria and gives spacey, happy, and slightly psychedelic sensations after only one or two hits. Some users feel creative and focused. The strong cerebral effects begin to diminish after about an hour, but the residual effects can last another two hours. These effects are coupled with pleasant body numbing sensations. Strong and trippy, this strain induces an insatiable appetite. This mega-strain may result in dry eyes and mouth and lead to paranoia, dizziness, and anxiety when consumed in high doses.
Moby Dick is designed specifically as a strong medical strain. It is excellent for daytime use though patients may feel lazy a few hours after use. The cerebral effects are often used to combat the symptoms of stress, anxiety, and depression. Patients that have lost their appetites, whether it's due to chemotherapy or other reasons, often choose this strain. The body high may ease mild aches and pains, but it is not strong enough to combat severe pain.
Moby Dick comes from the breeders at Dinafem (dinafem.org) who crossed two of their mother plants, a variety of Haze and a variety of White Widow. The strain has two phenotypes: one with Sativa-dominant characteristics that can reach up to twelve feet outdoors, while the other is a smaller, Indica-dominant phenotype, that is only seen about 35% of the time.
Description provided by Wikileaf.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Lyphe Group Ltd
From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.
At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.lyphegroup.com